A Day Up For RAPT Therapeutics, Inc.

Mon 25 Nov 19 at 05:30 PM
A Day Up For RAPT Therapeutics, Inc.

RAPT Therapeutics, Inc. (RAPT:NASDAQ) soared at $29.47, representing a gain of 44.2%. The stock got featured on our News Catalysts scanner on Thu 31 Oct 19 at 11:15 AM in the 'PUBLIC OFFERING' category. From Mon 04 Nov 19, the stock recorded 50.00% Up Days and 53.33% Green Days

The share price of the company has been moving sideways in recent weeks.

About RAPT Therapeutics, Inc. (RAPT:NASDAQ)

RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases.